Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
40
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Carvajal Alejandra | Chief Legal Officer | 4 | $0 | $0 | 2026-08-03 |
| Fuchs Charles S. | Director | 6 | $0 | $0 | 2026-07-24 |
| Su Zhen | Director | 4 | $0 | $0 | 2026-06-17 |
| Ashworth Alan | Director | 6 | $0 | $0 | 2026-06-17 |
| Mohindru Mani | Director | 7 | $0 | $0 | 2026-06-17 |
| Young Matthew P. | Director | 12 | $0 | $0 | 2026-06-17 |
| Gilbert Halley E | Director | 8 | $0 | $0 | 2026-06-17 |
| Meyers James R | Director | 9 | $0 | $0 | 2026-06-17 |
| Jones Elaine V | Director | 10 | $7.8K | $0 | 2026-06-17 |
| Ogden Christopher | SVP, Finance and Accounting | 33 | $0 | $179.9K | 2026-06-15 |
| BELVIN MARCIA | SVP, Chief Scientific Officer | 30 | $0 | $294.1K | 2026-03-17 |
| Chu Yu-Waye | Chief Medical Officer | 14 | $0 | $139.0K | 2026-03-17 |
| McCarthy Sean A. | President and CEO | 177 | $0 | $9.54M | 2026-03-17 |
| Lester Rachael | Chief Business Officer | 4 | $0 | $0 | 2026-02-02 |
| ROWLAND LLOYD A | General Counsel | 31 | $93.0K | $47.0K | 2025-03-18 |
| Landau Jeffrey B | Chief Financial Officer | 20 | $0 | $38.7K | 2024-08-20 |
| Campoy Carlos | Chief Financial Officer | 11 | $0 | $9.1K | 2023-03-16 |
| Peterson Amy C. | EVP, Chief Development Officer | 12 | $0 | $19.0K | 2023-03-16 |
| HANNAH ALISON L. | Chief Medical Officer | 8 | $0 | $8.0K | 2022-07-20 |
| GLUCK FREDERICK W | Director | 30 | $180.0K | $1.52M | 2022-06-15 |
| SCARLETT JOHN A | Director | 6 | $0 | $0 | 2021-06-16 |
| Knifsend Robin | Principal Accounting Officer | 2 | $0 | $0 | 2020-02-14 |
| Kavanaugh William Michael | Chief Scientific Officer and | 17 | $60.0K | $1.18M | 2020-02-14 |
| RAY DEBANJAN | Chief Financial Officer | 52 | $0 | $1.98M | 2019-01-25 |
| HUMPHREY RACHEL | Chief Medical Officer | 14 | $0 | $1.20M | 2019-01-25 |
| Huh Hoyoung | Director | 3 | $0 | $0 | 2018-06-13 |
| STARR KEVIN P | 10% Owner | 2 | $0 | $463.9K | 2017-10-18 |
| TEPPER ROBERT I | 10% Owner | 3 | $0 | $1.20M | 2017-10-04 |
| TRV GP, LLC | 10% Owner | 4 | $0 | $28.70M | 2017-07-13 |
| McCourt Marion | Director | 2 | $0 | $0 | 2017-06-20 |
| Exter Neil | Director | 5 | $0 | $0 | 2017-06-20 |
| Goeltz II Robert C. | Chief Financial Officer | 19 | $0 | $426.3K | 2017-05-12 |
| Canaan IX L.P. | Director, 10% Owner | 13 | $0 | $3.60M | 2017-03-27 |
| LADD CYNTHIA J | Senior VP and General Counsel | 5 | $36.0K | $0 | 2017-01-25 |
| Canaan Partners IX LLC | Director, 10% Owner | 23 | $0 | $3.33M | 2016-11-30 |
| SHANNON TIMOTHY M | Director | 34 | $0 | $6.93M | 2016-11-29 |
| Third Rock Ventures GP, L.P. | 10% Owner | 1 | $0 | $0 | 2016-11-07 |
| Hadley Harbor Master Investors (Cayman) L.P. | 10% Owner | 2 | $0 | $0 | 2015-10-14 |
| Flynn James E | 10% Owner | 6 | $7.50M | $0 | 2015-10-14 |
| LEVIN MARK J | 10% Owner | 3 | $0 | $0 | 2015-10-14 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Carvajal Alejandra | Chief Legal Officer | A Award deriv | 2026-08-03 | 2026-08-05 | 450,000 | — | $0 | 450,000 | SEC↗ |
| Carvajal Alejandra | Chief Legal Officer | A Award | 2026-08-03 | 2026-08-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Carvajal Alejandra | Chief Legal Officer | A Award deriv | 2026-08-03 | 2026-08-05 | 450,000 | — | $0 | 450,000 | SEC↗ |
| Carvajal Alejandra | Chief Legal Officer | A Award | 2026-08-03 | 2026-08-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Fuchs Charles S. | Director | A Award deriv | 2026-07-24 | 2026-07-30 | 118,000 | — | $0 | 118,000 | SEC↗ |
| Fuchs Charles S. | Director | A Award deriv | 2026-07-24 | 2026-07-30 | 118,000 | — | $0 | 118,000 | SEC↗ |
| Jones Elaine V | Director | A Award deriv | 2026-06-17 | 2026-06-22 | 59,000 | — | $0 | 59,000 | SEC↗ |
| Ashworth Alan | Director | A Award deriv | 2026-06-17 | 2026-06-22 | 59,000 | — | $0 | 59,000 | SEC↗ |
| Gilbert Halley E | Director | A Award deriv | 2026-06-17 | 2026-06-22 | 59,000 | — | $0 | 59,000 | SEC↗ |
| Meyers James R | Director | A Award deriv | 2026-06-17 | 2026-06-22 | 59,000 | — | $0 | 59,000 | SEC↗ |
| Mohindru Mani | Director | A Award deriv | 2026-06-17 | 2026-06-22 | 59,000 | — | $0 | 59,000 | SEC↗ |
| Young Matthew P. | Director | A Award deriv | 2026-06-17 | 2026-06-22 | 59,000 | — | $0 | 59,000 | SEC↗ |
| Su Zhen | Director | A Award deriv | 2026-06-17 | 2026-06-22 | 59,000 | — | $0 | 59,000 | SEC↗ |
| Ogden Christopher | Chief Financial Officer | S Sale | 2026-06-15 | 2026-06-17 | 1,624 | $3.05 | $5.0K | 295,324 | SEC↗ |
| Ogden Christopher | Chief Financial Officer | S Sale | 2026-03-17 | 2026-03-19 | 19,323 | $6.42 | $124.1K | 296,948 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | S Sale | 2026-03-17 | 2026-03-19 | 31,492 | $6.42 | $202.2K | 300,760 | SEC↗ |
| McCarthy Sean A. | CEO | S Sale | 2026-03-17 | 2026-03-19 | 118,969 | $6.42 | $763.8K | 1,078,922 | SEC↗ |
| Chu Yu-Waye | Chief Medical Officer | S Sale | 2026-03-17 | 2026-03-19 | 21,279 | $6.42 | $136.6K | 189,446 | SEC↗ |
| McCarthy Sean A. | CEO | A Award deriv | 2026-02-02 | 2026-02-04 | 980,000 | — | $0 | 980,000 | SEC↗ |
| Ogden Christopher | Chief Financial Officer | A Award deriv | 2026-02-02 | 2026-02-04 | 325,000 | — | $0 | 325,000 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | A Award deriv | 2026-02-02 | 2026-02-04 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Chu Yu-Waye | Chief Medical Officer | A Award deriv | 2026-02-02 | 2026-02-04 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Lester Rachael | Chief Business Officer | A Award deriv | 2026-02-02 | 2026-02-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Lester Rachael | Chief Business Officer | A Award deriv | 2026-02-02 | 2026-02-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| McCarthy Sean A. | CEO | A Award | 2026-02-02 | 2026-02-04 | 210,000 | — | $0 | 1,197,891 | SEC↗ |
| Ogden Christopher | Chief Financial Officer | A Award | 2026-02-02 | 2026-02-04 | 90,000 | — | $0 | 316,271 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | A Award | 2026-02-02 | 2026-02-04 | 60,000 | — | $0 | 332,252 | SEC↗ |
| Chu Yu-Waye | Chief Medical Officer | A Award | 2026-02-02 | 2026-02-04 | 75,000 | — | $0 | 210,725 | SEC↗ |
| Lester Rachael | Chief Business Officer | A Award | 2026-02-02 | 2026-02-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| McCarthy Sean A. | CEO | S Sale | 2025-11-06 | 2025-11-10 | 101,793 | $4.54 | $462.1K | 987,891 | SEC↗ |
| McCarthy Sean A. | CEO, Director | M Exercise deriv | 2025-11-06 | 2026-10-16 | 101,793 | — | $0 | 348,207 | SEC↗ |
| McCarthy Sean A. | CEO, Director | S Sale | 2025-11-06 | 2026-10-16 | 101,793 | $4.54 | $461.9K | 1,089,684 | SEC↗ |
| McCarthy Sean A. | CEO, Director | M Exercise | 2025-11-06 | 2026-10-16 | 101,793 | $1.59 | $161.9K | 1,191,477 | SEC↗ |
| Lester Rachael | Chief Business Officer | A Award deriv | 2025-10-20 | 2025-10-29 | 650,000 | — | $0 | 650,000 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | A Award deriv | 2025-09-26 | 2025-09-30 | 36,300 | — | $0 | 36,300 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | A Award deriv | 2025-09-26 | 2025-09-30 | 18,150 | — | $0 | 18,150 | SEC↗ |
| Ogden Christopher | Chief Financial Officer | A Award deriv | 2025-09-26 | 2025-09-30 | 78,250 | — | $0 | 78,250 | SEC↗ |
| Ogden Christopher | Chief Financial Officer | A Award deriv | 2025-09-26 | 2025-09-30 | 39,150 | — | $0 | 39,150 | SEC↗ |
| Chu Yu-Waye | Chief Medical Officer | A Award deriv | 2025-09-26 | 2025-09-30 | 87,500 | — | $0 | 87,500 | SEC↗ |
| Chu Yu-Waye | Chief Medical Officer | A Award deriv | 2025-09-26 | 2025-09-30 | 43,750 | — | $0 | 43,750 | SEC↗ |
| McCarthy Sean A. | CEO | A Award deriv | 2025-09-26 | 2025-09-30 | 285,000 | — | $0 | 285,000 | SEC↗ |
| McCarthy Sean A. | CEO | A Award deriv | 2025-09-26 | 2025-09-30 | 570,000 | — | $0 | 570,000 | SEC↗ |
| McCarthy Sean A. | CEO | S Sale | 2025-06-16 | 2025-06-17 | 55,511 | $2.69 | $149.3K | 1,089,684 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | S Sale | 2025-06-16 | 2025-06-17 | 13,884 | $2.69 | $37.3K | 272,252 | SEC↗ |
| Ogden Christopher | Chief Financial Officer | S Sale | 2025-06-16 | 2025-06-17 | 10,614 | $2.69 | $28.6K | 226,271 | SEC↗ |
| McCarthy Sean A. | CEO | M Exercise deriv | 2025-06-13 | 2025-06-17 | 150,000 | — | $0 | 0 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | M Exercise deriv | 2025-06-13 | 2025-06-17 | 37,500 | — | $0 | 0 | SEC↗ |
| Ogden Christopher | Chief Financial Officer | M Exercise deriv | 2025-06-13 | 2025-06-17 | 37,500 | — | $0 | 0 | SEC↗ |
| McCarthy Sean A. | CEO | M Exercise | 2025-06-13 | 2025-06-17 | 150,000 | — | $0 | 1,145,195 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | M Exercise | 2025-06-13 | 2025-06-17 | 37,500 | — | $0 | 286,136 | SEC↗ |
| Ogden Christopher | Chief Financial Officer | S Sale | 2025-06-13 | 2025-06-17 | 1,641 | $2.95 | $4.8K | 199,385 | SEC↗ |
| Ogden Christopher | Chief Financial Officer | M Exercise | 2025-06-13 | 2025-06-17 | 37,500 | — | $0 | 236,885 | SEC↗ |
| Ashworth Alan | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 38,000 | — | $0 | 38,000 | SEC↗ |
| Gilbert Halley E | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 38,000 | — | $0 | 38,000 | SEC↗ |
| Jones Elaine V | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 38,000 | — | $0 | 38,000 | SEC↗ |
| Meyers James R | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 38,000 | — | $0 | 38,000 | SEC↗ |
| Mohindru Mani | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 38,000 | — | $0 | 38,000 | SEC↗ |
| Young Matthew P. | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 38,000 | — | $0 | 38,000 | SEC↗ |
| Su Zhen | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 38,000 | — | $0 | 38,000 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | S Sale | 2025-03-18 | 2025-03-20 | 19,512 | $0.60 | $11.7K | 248,636 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | S Sale | 2025-03-18 | 2025-03-20 | 10,203 | $0.60 | $6.1K | 120,594 | SEC↗ |
| Chu Yu-Waye | Chief Medical Officer | S Sale | 2025-03-18 | 2025-03-20 | 4,025 | $0.60 | $2.4K | 135,725 | SEC↗ |
| Ogden Christopher | Chief Financial Officer | S Sale | 2025-03-18 | 2025-03-20 | 8,551 | $0.60 | $5.1K | 201,026 | SEC↗ |
| McCarthy Sean A. | CEO | S Sale | 2025-03-18 | 2025-03-20 | 37,656 | $0.60 | $22.6K | 995,195 | SEC↗ |
| McCarthy Sean A. | CEO | A Award deriv | 2025-02-04 | 2025-02-06 | 390,000 | — | $0 | 390,000 | SEC↗ |
| McCarthy Sean A. | CEO | A Award deriv | 2025-02-04 | 2025-02-06 | 800,000 | — | $0 | 800,000 | SEC↗ |
| Ogden Christopher | Chief Financial Officer | A Award deriv | 2025-02-04 | 2025-02-06 | 225,000 | — | $0 | 225,000 | SEC↗ |
| Ogden Christopher | Chief Financial Officer | A Award deriv | 2025-02-04 | 2025-02-06 | 115,000 | — | $0 | 115,000 | SEC↗ |
| Chu Yu-Waye | Chief Medical Officer | A Award deriv | 2025-02-04 | 2025-02-06 | 115,000 | — | $0 | 115,000 | SEC↗ |
| Chu Yu-Waye | Chief Medical Officer | A Award deriv | 2025-02-04 | 2025-02-06 | 238,000 | — | $0 | 238,000 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | A Award deriv | 2025-02-04 | 2025-02-06 | 140,000 | — | $0 | 140,000 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | A Award deriv | 2025-02-04 | 2025-02-06 | 115,000 | — | $0 | 115,000 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | A Award deriv | 2025-02-04 | 2025-02-10 | 115,000 | — | $0 | 115,000 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | A Award deriv | 2025-02-04 | 2025-02-10 | 150,000 | — | $0 | 150,000 | SEC↗ |
| McCarthy Sean A. | CEO | A Award | 2025-02-04 | 2025-02-06 | 180,000 | — | $0 | 837,851 | SEC↗ |
| McCarthy Sean A. | CEO | A Award | 2025-02-04 | 2025-02-06 | 195,000 | — | $0 | 1,032,851 | SEC↗ |
| Ogden Christopher | Chief Financial Officer | A Award | 2025-02-04 | 2025-02-06 | 57,500 | — | $0 | 209,577 | SEC↗ |
| Ogden Christopher | Chief Financial Officer | A Award | 2025-02-04 | 2025-02-06 | 44,000 | — | $0 | 152,077 | SEC↗ |
| Chu Yu-Waye | Chief Medical Officer | A Award | 2025-02-04 | 2025-02-06 | 56,000 | — | $0 | 82,250 | SEC↗ |
| Chu Yu-Waye | Chief Medical Officer | A Award | 2025-02-04 | 2025-02-06 | 57,500 | — | $0 | 139,750 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | A Award | 2025-02-04 | 2025-02-06 | 57,500 | — | $0 | 263,148 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | A Award | 2025-02-04 | 2025-02-06 | 30,000 | — | $0 | 205,648 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | A Award | 2025-02-04 | 2025-02-10 | 35,000 | — | $0 | 210,648 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | A Award | 2025-02-04 | 2025-02-10 | 57,500 | — | $0 | 268,148 | SEC↗ |
| McCarthy Sean A. | CEO | M Exercise deriv | 2024-08-20 | 2024-08-22 | 37,500 | — | $0 | 0 | SEC↗ |
| Ogden Christopher | Chief Financial Officer | M Exercise deriv | 2024-08-20 | 2024-08-22 | 6,875 | — | $0 | 0 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | M Exercise deriv | 2024-08-20 | 2024-08-22 | 11,250 | — | $0 | 0 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | M Exercise deriv | 2024-08-20 | 2024-08-22 | 11,250 | — | $0 | 0 | SEC↗ |
| Landau Jeffrey B | Chief Business Officer | M Exercise deriv | 2024-08-20 | 2024-08-22 | 11,250 | — | $0 | 0 | SEC↗ |
| McCarthy Sean A. | CEO | M Exercise | 2024-08-20 | 2024-08-22 | 37,500 | — | $0 | 671,749 | SEC↗ |
| McCarthy Sean A. | CEO | S Sale | 2024-08-20 | 2024-08-22 | 13,898 | $1.23 | $17.1K | 657,851 | SEC↗ |
| Ogden Christopher | Chief Financial Officer | S Sale | 2024-08-20 | 2024-08-22 | 1,984 | $1.23 | $2.4K | 108,077 | SEC↗ |
| Ogden Christopher | Chief Financial Officer | M Exercise | 2024-08-20 | 2024-08-22 | 6,875 | — | $0 | 110,061 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | S Sale | 2024-08-20 | 2024-08-22 | 4,181 | $1.23 | $5.1K | 130,797 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | M Exercise | 2024-08-20 | 2024-08-22 | 11,250 | — | $0 | 134,978 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | S Sale | 2024-08-20 | 2024-08-22 | 4,181 | $1.23 | $5.1K | 175,648 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | M Exercise | 2024-08-20 | 2024-08-22 | 11,250 | — | $0 | 179,829 | SEC↗ |
| Landau Jeffrey B | Chief Business Officer | S Sale | 2024-08-20 | 2024-08-22 | 4,181 | $1.23 | $5.1K | 119,056 | SEC↗ |
| Landau Jeffrey B | Chief Business Officer | M Exercise | 2024-08-20 | 2024-08-22 | 11,250 | — | $0 | 123,237 | SEC↗ |
| Ogden Christopher | Chief Financial Officer | A Award deriv | 2024-06-12 | 2024-06-14 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Ogden Christopher | Chief Financial Officer | A Award | 2024-06-12 | 2024-06-14 | 17,500 | — | $0 | 103,186 | SEC↗ |
| Ashworth Alan | Director | A Award deriv | 2024-05-15 | 2024-05-17 | 38,000 | — | $0 | 38,000 | SEC↗ |
| Gilbert Halley E | Director | A Award deriv | 2024-05-15 | 2024-05-17 | 38,000 | — | $0 | 38,000 | SEC↗ |
| Jones Elaine V | Director | A Award deriv | 2024-05-15 | 2024-05-17 | 38,000 | — | $0 | 38,000 | SEC↗ |
| Meyers James R | Director | A Award deriv | 2024-05-15 | 2024-05-17 | 38,000 | — | $0 | 38,000 | SEC↗ |
| Mohindru Mani | Director | A Award deriv | 2024-05-15 | 2024-05-17 | 38,000 | — | $0 | 38,000 | SEC↗ |
| Su Zhen | Director | A Award deriv | 2024-05-15 | 2024-05-17 | 38,000 | — | $0 | 38,000 | SEC↗ |
| Young Matthew P. | Director | A Award deriv | 2024-05-15 | 2024-05-17 | 38,000 | — | $0 | 38,000 | SEC↗ |
| McCarthy Sean A. | CEO | M Exercise deriv | 2024-03-26 | 2024-03-28 | 109,768 | — | $0 | 0 | SEC↗ |
| McCarthy Sean A. | CEO | M Exercise | 2024-03-26 | 2024-03-28 | 109,768 | $1.57 | $172.3K | 634,249 | SEC↗ |
| Su Zhen | Director | A Award deriv | 2024-03-20 | 2024-03-22 | 76,000 | — | $0 | 76,000 | SEC↗ |
| Landau Jeffrey B | Chief Business Officer | S Sale | 2024-03-19 | 2024-03-21 | 6,562 | $2.09 | $13.7K | 110,060 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | S Sale | 2024-03-19 | 2024-03-21 | 12,795 | $2.09 | $26.7K | 168,579 | SEC↗ |
| Ogden Christopher | SVP, Finance and Accounting | S Sale | 2024-03-19 | 2024-03-21 | 2,971 | $2.09 | $6.2K | 85,686 | SEC↗ |
| McCarthy Sean A. | CEO | S Sale | 2024-03-19 | 2024-03-21 | 20,223 | $2.09 | $42.3K | 524,481 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | S Sale | 2024-03-19 | 2024-03-21 | 5,268 | $2.09 | $11.0K | 117,728 | SEC↗ |
| Chu Yu-Waye | Chief Medical Officer | A Award deriv | 2024-01-18 | 2024-01-19 | 122,500 | — | $0 | 122,500 | SEC↗ |
| Chu Yu-Waye | Chief Medical Officer | A Award deriv | 2024-01-18 | 2024-01-19 | 75,000 | — | $0 | 75,000 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | A Award deriv | 2024-01-18 | 2024-01-19 | 122,500 | — | $0 | 122,500 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | A Award deriv | 2024-01-18 | 2024-01-19 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Landau Jeffrey B | Chief Business Officer | A Award deriv | 2024-01-18 | 2024-01-19 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Landau Jeffrey B | Chief Business Officer | A Award deriv | 2024-01-18 | 2024-01-19 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Ogden Christopher | SVP, Finance and Accounting | A Award deriv | 2024-01-18 | 2024-01-19 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Ogden Christopher | SVP, Finance and Accounting | A Award deriv | 2024-01-18 | 2024-01-19 | 154,000 | — | $0 | 154,000 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | A Award deriv | 2024-01-18 | 2024-01-19 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | A Award deriv | 2024-01-18 | 2024-01-19 | 100,000 | — | $0 | 100,000 | SEC↗ |
| McCarthy Sean A. | CEO | A Award deriv | 2024-01-18 | 2024-01-19 | 420,000 | — | $0 | 420,000 | SEC↗ |
| McCarthy Sean A. | CEO | A Award deriv | 2024-01-18 | 2024-01-19 | 260,000 | — | $0 | 260,000 | SEC↗ |
| Chu Yu-Waye | Chief Medical Officer | A Award | 2024-01-18 | 2024-01-19 | 26,250 | — | $0 | 26,250 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | A Award | 2024-01-18 | 2024-01-19 | 26,250 | — | $0 | 181,374 | SEC↗ |
| Landau Jeffrey B | Chief Business Officer | A Award | 2024-01-18 | 2024-01-19 | 30,000 | — | $0 | 116,622 | SEC↗ |
| Ogden Christopher | SVP, Finance and Accounting | A Award | 2024-01-18 | 2024-01-19 | 40,000 | — | $0 | 88,657 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | A Award | 2024-01-18 | 2024-01-19 | 25,000 | — | $0 | 122,996 | SEC↗ |
| McCarthy Sean A. | CEO | A Award | 2024-01-18 | 2024-01-19 | 90,000 | — | $0 | 544,704 | SEC↗ |
| Ogden Christopher | SVP, Finance and Accounting | S Sale | 2023-12-20 | 2023-12-22 | 1,990 | $1.38 | $2.7K | 48,657 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | S Sale | 2023-12-20 | 2023-12-22 | 4,077 | $1.38 | $5.6K | 97,996 | SEC↗ |
| Landau Jeffrey B | Chief Business Officer | S Sale | 2023-12-20 | 2023-12-22 | 4,077 | $1.38 | $5.6K | 86,622 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | S Sale | 2023-12-20 | 2023-12-22 | 4,077 | $1.38 | $5.6K | 155,124 | SEC↗ |
| McCarthy Sean A. | CEO | S Sale | 2023-12-20 | 2023-12-22 | 13,551 | $1.38 | $18.7K | 454,704 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | M Exercise deriv | 2023-12-17 | 2023-12-19 | 11,250 | — | $0 | 11,250 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | M Exercise deriv | 2023-12-17 | 2023-12-19 | 11,250 | — | $0 | 11,250 | SEC↗ |
| Landau Jeffrey B | Chief Business Officer | M Exercise deriv | 2023-12-17 | 2023-12-19 | 11,250 | — | $0 | 11,250 | SEC↗ |
| McCarthy Sean A. | CEO | M Exercise deriv | 2023-12-17 | 2023-12-19 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Ogden Christopher | SVP, Finance and Accounting | M Exercise deriv | 2023-12-17 | 2023-12-19 | 6,875 | — | $0 | 6,875 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | M Exercise | 2023-12-17 | 2023-12-19 | 11,250 | — | $0 | 159,201 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | M Exercise | 2023-12-17 | 2023-12-19 | 11,250 | — | $0 | 102,073 | SEC↗ |
| Landau Jeffrey B | Chief Business Officer | M Exercise | 2023-12-17 | 2023-12-19 | 11,250 | — | $0 | 90,699 | SEC↗ |
| McCarthy Sean A. | CEO | M Exercise | 2023-12-17 | 2023-12-19 | 37,500 | — | $0 | 468,255 | SEC↗ |
| Ogden Christopher | SVP, Finance and Accounting | M Exercise | 2023-12-17 | 2023-12-19 | 6,875 | — | $0 | 50,647 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | S Sale | 2023-09-22 | 2023-09-22 | 5,486 | $1.30 | $7.1K | 80,609 | SEC↗ |
| McCarthy Sean A. | CEO | S Sale | 2023-09-22 | 2023-09-22 | 14,601 | $1.30 | $19.0K | 430,755 | SEC↗ |
| Landau Jeffrey B | Chief Business Officer | S Sale | 2023-09-22 | 2023-09-22 | 4,119 | $1.30 | $5.4K | 76,379 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | S Sale | 2023-09-22 | 2023-09-22 | 4,119 | $1.30 | $5.4K | 147,951 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | A Award | 2023-09-20 | 2023-09-22 | 15,000 | — | $0 | 86,095 | SEC↗ |
| McCarthy Sean A. | CEO | A Award | 2023-09-20 | 2023-09-22 | 40,000 | — | $0 | 445,356 | SEC↗ |
| Landau Jeffrey B | Chief Business Officer | A Award | 2023-09-20 | 2023-09-22 | 11,250 | — | $0 | 80,498 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | A Award | 2023-09-20 | 2023-09-22 | 11,250 | — | $0 | 152,070 | SEC↗ |
| Chu Yu-Waye | Chief Medical Officer | A Award deriv | 2023-07-19 | 2023-07-20 | 375,000 | — | $0 | 375,000 | SEC↗ |
| Jones Elaine V | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Gilbert Halley E | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Ashworth Alan | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Young Matthew P. | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Mohindru Mani | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Meyers James R | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| McCarthy Sean A. | CEO | M Exercise deriv | 2023-05-19 | 2023-05-23 | 16,535 | — | $0 | 119,536 | SEC↗ |
| McCarthy Sean A. | CEO | M Exercise | 2023-05-19 | 2023-05-23 | 16,535 | $1.57 | $26.0K | 405,356 | SEC↗ |
| Jones Elaine V | Director | P Buy | 2023-03-29 | 2023-03-31 | 5,000 | $1.55 | $7.8K | 5,142 | SEC↗ |
| BELVIN MARCIA | SVP, Chief Scientific Office | A Award | 2023-03-22 | 2023-03-29 | 60,000 | — | $0 | 140,820 | SEC↗ |
| Peterson Amy C. | EVP, Chief Development Offic | S Sale | 2023-03-16 | 2023-03-20 | 4,257 | $1.98 | $8.4K | 58,433 | SEC↗ |
| Landau Jeffrey B | Chief Financial Officer | S Sale | 2023-03-16 | 2023-03-20 | 1,477 | $1.98 | $2.9K | 69,248 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | S Sale | 2023-03-16 | 2023-03-20 | 2,037 | $1.98 | $4.0K | 71,095 | SEC↗ |
| Campoy Carlos | Chief Financial Officer | S Sale | 2023-03-16 | 2023-03-20 | 1,748 | $1.98 | $3.5K | 38,224 | SEC↗ |
| McCarthy Sean A. | CEO | S Sale | 2023-03-16 | 2023-03-20 | 7,121 | $1.88 | $13.4K | 388,821 | SEC↗ |
| Ogden Christopher | SVP, Finance and Accounting | S Sale | 2023-03-16 | 2023-03-20 | 516 | $1.98 | $1.0K | 37,772 | SEC↗ |
| Ogden Christopher | SVP, Finance and Accounting | A Award deriv | 2023-02-02 | 2023-02-06 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Ogden Christopher | SVP, Finance and Accounting | A Award deriv | 2023-02-02 | 2023-02-06 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | A Award deriv | 2023-02-02 | 2023-02-06 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | A Award deriv | 2023-02-02 | 2023-02-06 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Landau Jeffrey B | Chief Business Officer | A Award deriv | 2023-02-02 | 2023-02-06 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Landau Jeffrey B | Chief Business Officer | A Award deriv | 2023-02-02 | 2023-02-06 | 100,000 | — | $0 | 100,000 | SEC↗ |
| McCarthy Sean A. | CEO | A Award deriv | 2023-02-02 | 2023-02-06 | 315,000 | — | $0 | 315,000 | SEC↗ |
| McCarthy Sean A. | CEO | A Award deriv | 2023-02-02 | 2023-02-06 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Ogden Christopher | SVP, Finance and Accounting | A Award | 2023-02-02 | 2023-02-06 | 25,000 | — | $0 | 38,288 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | A Award | 2023-02-02 | 2023-02-06 | 25,000 | — | $0 | 73,132 | SEC↗ |
| Landau Jeffrey B | Chief Business Officer | A Award | 2023-02-02 | 2023-02-06 | 40,000 | — | $0 | 70,725 | SEC↗ |
| McCarthy Sean A. | CEO | A Award | 2023-02-02 | 2023-02-06 | 105,000 | — | $0 | 395,942 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | A Award deriv | 2022-08-10 | 2022-08-12 | 22,500 | — | $0 | 22,500 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | A Award deriv | 2022-08-10 | 2022-08-12 | 135,000 | — | $0 | 135,000 | SEC↗ |
| Ogden Christopher | SVP, Finance and Accounting | A Award deriv | 2022-08-10 | 2022-08-12 | 82,500 | — | $0 | 82,500 | SEC↗ |
| Ogden Christopher | SVP, Finance and Accounting | A Award deriv | 2022-08-10 | 2022-08-12 | 13,750 | — | $0 | 13,750 | SEC↗ |
| Landau Jeffrey B | Chief Business Officer | A Award deriv | 2022-08-10 | 2022-08-12 | 135,000 | — | $0 | 135,000 | SEC↗ |
| Landau Jeffrey B | Chief Business Officer | A Award deriv | 2022-08-10 | 2022-08-12 | 22,500 | — | $0 | 22,500 | SEC↗ |
| McCarthy Sean A. | CEO | A Award deriv | 2022-08-10 | 2022-08-12 | 75,000 | — | $0 | 75,000 | SEC↗ |
| McCarthy Sean A. | CEO | A Award deriv | 2022-08-10 | 2022-08-12 | 450,000 | — | $0 | 450,000 | SEC↗ |
| Campoy Carlos | Chief Financial Officer | S Sale | 2022-07-20 | 2022-07-21 | 3,949 | $1.42 | $5.6K | 39,972 | SEC↗ |
| HANNAH ALISON L. | Chief Medical Officer | S Sale | 2022-07-20 | 2022-07-21 | 5,602 | $1.42 | $8.0K | 31,898 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | S Sale | 2022-07-20 | 2022-07-21 | 5,602 | $1.42 | $8.0K | 43,689 | SEC↗ |
| McCarthy Sean A. | President and CEO | S Sale | 2022-07-20 | 2022-07-21 | 14,911 | $1.42 | $21.2K | 290,942 | SEC↗ |
| Landau Jeffrey B | Chief Business Officer | S Sale | 2022-07-20 | 2022-07-21 | 4,206 | $1.42 | $6.0K | 30,725 | SEC↗ |
| Peterson Amy C. | EVP, Chief Development Offic | S Sale | 2022-07-20 | 2022-07-21 | 7,463 | $1.42 | $10.6K | 62,690 | SEC↗ |
| Campoy Carlos | Chief Financial Officer | A Award | 2022-07-19 | 2022-07-21 | 15,000 | — | $0 | 43,921 | SEC↗ |
| HANNAH ALISON L. | Chief Medical Officer | A Award | 2022-07-19 | 2022-07-21 | 15,000 | — | $0 | 37,500 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | A Award | 2022-07-19 | 2022-07-21 | 15,000 | — | $0 | 49,291 | SEC↗ |
| McCarthy Sean A. | President and CEO | A Award | 2022-07-19 | 2022-07-21 | 40,000 | — | $0 | 305,853 | SEC↗ |
| Landau Jeffrey B | Chief Business Officer | A Award | 2022-07-19 | 2022-07-21 | 11,250 | — | $0 | 34,931 | SEC↗ |
| Peterson Amy C. | EVP, Chief Development Offic | A Award | 2022-07-19 | 2022-07-21 | 20,000 | — | $0 | 70,153 | SEC↗ |
| Ashworth Alan | Director | A Award deriv | 2022-06-15 | 2022-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Jones Elaine V | Director | A Award deriv | 2022-06-15 | 2022-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| GLUCK FREDERICK W | Director | A Award deriv | 2022-06-15 | 2022-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Gilbert Halley E | Director | A Award deriv | 2022-06-15 | 2022-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Meyers James R | Director | A Award deriv | 2022-06-15 | 2022-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Mohindru Mani | Director | A Award deriv | 2022-06-15 | 2022-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Young Matthew P. | Director | A Award deriv | 2022-06-15 | 2022-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| McCarthy Sean A. | President and CEO | M Exercise deriv | 2022-05-09 | 2022-05-11 | 66,742 | — | $0 | 0 | SEC↗ |
| McCarthy Sean A. | President and CEO | M Exercise deriv | 2022-05-09 | 2022-05-11 | 24,189 | — | $0 | 0 | SEC↗ |
| McCarthy Sean A. | President and CEO | M Exercise | 2022-05-09 | 2022-05-11 | 66,742 | $0.95 | $63.4K | 241,664 | SEC↗ |
| McCarthy Sean A. | President and CEO | M Exercise | 2022-05-09 | 2022-05-11 | 24,189 | $0.95 | $23.0K | 265,853 | SEC↗ |
| McCarthy Sean A. | President and CEO | A Award deriv | 2022-02-02 | 2022-02-04 | 450,000 | — | $0 | 450,000 | SEC↗ |
| Campoy Carlos | Chief Financial Officer | A Award deriv | 2022-02-02 | 2022-02-04 | 135,000 | — | $0 | 135,000 | SEC↗ |
| HANNAH ALISON L. | Chief Medical Officer | A Award deriv | 2022-02-02 | 2022-02-04 | 135,000 | — | $0 | 135,000 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | A Award deriv | 2022-02-02 | 2022-02-04 | 135,000 | — | $0 | 135,000 | SEC↗ |
| Peterson Amy C. | EVP, Chief Development Offic | A Award deriv | 2022-02-02 | 2022-02-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| McCarthy Sean A. | President and CEO | A Award | 2022-02-02 | 2022-02-04 | 75,000 | — | $0 | 174,922 | SEC↗ |
| Campoy Carlos | Chief Financial Officer | A Award | 2022-02-02 | 2022-02-04 | 22,500 | — | $0 | 28,921 | SEC↗ |
| HANNAH ALISON L. | Chief Medical Officer | A Award | 2022-02-02 | 2022-02-04 | 22,500 | — | $0 | 22,500 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | A Award | 2022-02-02 | 2022-02-04 | 22,500 | — | $0 | 34,291 | SEC↗ |
| Peterson Amy C. | EVP, Chief Development Offic | A Award | 2022-02-02 | 2022-02-04 | 40,000 | — | $0 | 46,421 | SEC↗ |
| HANNAH ALISON L. | Chief Medical Officer | A Award deriv | 2021-10-24 | 2021-10-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| HANNAH ALISON L. | Chief Medical Officer | A Award deriv | 2021-10-24 | 2021-10-26 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Campoy Carlos | Chief Financial Officer | A Award deriv | 2021-10-24 | 2021-10-26 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Campoy Carlos | Chief Financial Officer | A Award deriv | 2021-10-24 | 2021-10-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Peterson Amy C. | EVP, Chief Development Offic | A Award deriv | 2021-10-24 | 2021-10-26 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Peterson Amy C. | EVP, Chief Development Offic | A Award deriv | 2021-10-24 | 2021-10-26 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | A Award deriv | 2021-10-24 | 2021-10-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | A Award deriv | 2021-10-24 | 2021-10-26 | 40,000 | — | $0 | 40,000 | SEC↗ |
| McCarthy Sean A. | President and CEO | A Award deriv | 2021-10-24 | 2021-10-26 | 100,000 | — | $0 | 100,000 | SEC↗ |
| McCarthy Sean A. | President and CEO | A Award deriv | 2021-10-24 | 2021-10-26 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Ashworth Alan | Director | A Award deriv | 2021-09-29 | 2021-10-07 | 40,000 | — | $0 | 40,000 | SEC↗ |
| McCarthy Sean A. | President and CEO | M Exercise deriv | 2021-08-11 | 2021-08-13 | 92,113 | — | $0 | 0 | SEC↗ |
| McCarthy Sean A. | President and CEO | M Exercise | 2021-08-11 | 2021-08-13 | 92,113 | $1.13 | $104.1K | 99,922 | SEC↗ |
| Gilbert Halley E | Director | A Award deriv | 2021-06-16 | 2021-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GLUCK FREDERICK W | Director | A Award deriv | 2021-06-16 | 2021-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Jones Elaine V | Director | A Award deriv | 2021-06-16 | 2021-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Meyers James R | Director | A Award deriv | 2021-06-16 | 2021-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SCARLETT JOHN A | Director | A Award deriv | 2021-06-16 | 2021-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Young Matthew P. | Director | A Award deriv | 2021-06-16 | 2021-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Mohindru Mani | Director | A Award deriv | 2021-06-16 | 2021-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| McCarthy Sean A. | President and CEO | S Sale | 2021-06-16 | 2021-06-21 | 100,000 | $7.04 | $704.0K | 93,118 | SEC↗ |
| McCarthy Sean A. | President and CEO | M Exercise deriv | 2021-06-14 | 2021-06-16 | 30 | — | $0 | 92,113 | SEC↗ |
| McCarthy Sean A. | President and CEO | M Exercise deriv | 2021-06-14 | 2021-06-16 | 10 | — | $0 | 66,742 | SEC↗ |
| McCarthy Sean A. | President and CEO | M Exercise | 2021-06-14 | 2021-06-16 | 30 | $1.13 | $34 | 7,839 | SEC↗ |
| McCarthy Sean A. | President and CEO | M Exercise | 2021-06-14 | 2021-06-16 | 10 | $0.95 | $10 | 7,849 | SEC↗ |
| Peterson Amy C. | EVP, Chief Development Offic | A Award | 2021-05-31 | 2021-06-08 | 3,320 | $6.09 | $20.2K | 6,421 | SEC↗ |
| Campoy Carlos | Chief Financial Officer | A Award | 2021-05-31 | 2021-06-08 | 3,320 | $6.09 | $20.2K | 6,421 | SEC↗ |
| McCarthy Sean A. | President and CEO | M Exercise deriv | 2021-03-31 | 2021-04-02 | 100,000 | — | $0 | 92,143 | SEC↗ |
| McCarthy Sean A. | President and CEO | S Sale | 2021-03-31 | 2021-04-02 | 100,000 | $7.49 | $749.0K | 206,894 | SEC↗ |
| McCarthy Sean A. | President and CEO | M Exercise | 2021-03-31 | 2021-04-02 | 100,000 | $1.13 | $113.0K | 306,894 | SEC↗ |
| McCarthy Sean A. | President and CEO | A Award deriv | 2021-02-27 | 2021-03-02 | 200,000 | — | $0 | 200,000 | SEC↗ |
| McCarthy Sean A. | President and CEO | A Award deriv | 2021-02-26 | 2021-03-02 | 400,000 | — | $0 | 400,000 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | A Award deriv | 2021-02-26 | 2021-03-02 | 125,000 | — | $0 | 125,000 | SEC↗ |
| HANNAH ALISON L. | Chief Medical Officer | A Award deriv | 2021-02-26 | 2021-03-02 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Campoy Carlos | Chief Financial Officer | A Award deriv | 2021-02-26 | 2021-03-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Peterson Amy C. | EVP, Chief Development Offic | A Award deriv | 2021-02-26 | 2021-03-02 | 250,000 | — | $0 | 250,000 | SEC↗ |
| McCarthy Sean A. | President and CEO | M Exercise deriv | 2020-12-23 | 2020-12-28 | 100,000 | — | $0 | 192,143 | SEC↗ |
| McCarthy Sean A. | President and CEO | M Exercise | 2020-12-23 | 2020-12-28 | 100,000 | $1.13 | $113.0K | 206,894 | SEC↗ |
| Mohindru Mani | Director | A Award deriv | 2020-12-16 | 2020-12-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Campoy Carlos | Chief Financial Officer | A Award | 2020-11-30 | 2020-12-07 | 3,101 | $6.39 | $19.8K | 3,101 | SEC↗ |
| McCarthy Sean A. | President and CEO | A Award | 2020-11-30 | 2020-12-07 | 930 | $6.39 | $5.9K | 106,894 | SEC↗ |
| Peterson Amy C. | EVP, Chief Development Offic | A Award | 2020-11-30 | 2020-12-07 | 3,101 | $6.39 | $19.8K | 3,101 | SEC↗ |
| McCarthy Sean A. | President and CEO | M Exercise deriv | 2020-09-21 | 2020-09-23 | 20,500 | — | $0 | 0 | SEC↗ |
| McCarthy Sean A. | President and CEO | M Exercise | 2020-09-21 | 2020-09-23 | 20,500 | $6.61 | $135.5K | 105,964 | SEC↗ |
| Fuchs Charles S. | Director | A Award deriv | 2020-06-17 | 2020-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Gilbert Halley E | Director | A Award deriv | 2020-06-17 | 2020-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GLUCK FREDERICK W | Director | A Award deriv | 2020-06-17 | 2020-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Jones Elaine V | Director | A Award deriv | 2020-06-17 | 2020-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Young Matthew P. | Director | A Award deriv | 2020-06-17 | 2020-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SCARLETT JOHN A | Director | A Award deriv | 2020-06-17 | 2020-06-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Meyers James R | Director | A Award deriv | 2020-06-17 | 2020-06-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| McCarthy Sean A. | President and CEO | A Award | 2020-05-29 | 2020-06-02 | 1,158 | $5.11 | $5.9K | 85,464 | SEC↗ |
| McCarthy Sean A. | President and CEO | M Exercise deriv | 2020-05-12 | 2020-05-14 | 36,000 | — | $0 | 292,143 | SEC↗ |
| McCarthy Sean A. | President and CEO | M Exercise | 2020-05-12 | 2020-05-14 | 36,000 | $1.13 | $40.7K | 120,306 | SEC↗ |
| McCarthy Sean A. | President and CEO | S Sale | 2020-05-12 | 2020-05-14 | 36,000 | $15.00 | $540.0K | 84,306 | SEC↗ |
| Gilbert Halley E | Director | A Award deriv | 2020-04-27 | 2020-04-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Campoy Carlos | Chief Financial Officer | A Award deriv | 2020-03-23 | 2020-03-25 | 350,000 | — | $0 | 350,000 | SEC↗ |
| McCarthy Sean A. | President and CEO | A Award deriv | 2020-02-14 | 2020-02-19 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Peterson Amy C. | EVP, Chief Development Offic | A Award deriv | 2020-02-14 | 2020-02-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ROWLAND LLOYD A | General Counsel | A Award deriv | 2020-02-14 | 2020-02-19 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Kavanaugh William Michael | CSO, Head Res.&Non-Clin. Dev | A Award deriv | 2020-02-14 | 2020-02-19 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Knifsend Robin | Principal Accounting Officer | A Award deriv | 2020-02-14 | 2020-02-21 | 34,000 | — | $0 | 34,000 | SEC↗ |
| HANNAH ALISON L. | Chief Medical Officer | A Award deriv | 2020-02-03 | 2020-02-05 | 250,000 | — | $0 | 250,000 | SEC↗ |
| McCarthy Sean A. | President and CEO | A Award | 2019-11-30 | 2019-12-16 | 1,080 | $5.32 | $5.7K | 84,306 | SEC↗ |
| Peterson Amy C. | EVP, Chief Development Offic | A Award deriv | 2019-10-15 | 2019-10-16 | 400,000 | — | $0 | 400,000 | SEC↗ |
| McCarthy Sean A. | President and CEO | G Gift | 2019-09-30 | 2021-06-08 | 4,500 | — | $0 | 7,809 | SEC↗ |
| Meyers James R | Director | A Award deriv | 2019-06-19 | 2019-06-21 | 14,000 | — | $0 | 14,000 | SEC↗ |
| Jones Elaine V | Director | A Award deriv | 2019-06-19 | 2019-06-21 | 14,000 | — | $0 | 14,000 | SEC↗ |
| Fuchs Charles S. | Director | A Award deriv | 2019-06-19 | 2019-06-21 | 14,000 | — | $0 | 14,000 | SEC↗ |
| GLUCK FREDERICK W | Director | A Award deriv | 2019-06-19 | 2019-06-21 | 14,000 | — | $0 | 14,000 | SEC↗ |
| Young Matthew P. | Director | A Award deriv | 2019-06-19 | 2019-06-21 | 14,000 | — | $0 | 14,000 | SEC↗ |
| SCARLETT JOHN A | Director | A Award deriv | 2019-06-19 | 2019-06-21 | 14,000 | — | $0 | 14,000 | SEC↗ |
| McCarthy Sean A. | President and CEO | A Award | 2019-05-31 | 2019-06-04 | 695 | $8.21 | $5.7K | 83,226 | SEC↗ |